In other cancer types, including AML, T‐ALL, and neuroblastoma, MYC overexpression is associated with amplification of super‐enhancers downstream of the MYC gene37, 38; reviewed in Shi et al.39These findings suggest that enhancer amplification might be a common mechanism of oncogene activation. This evidence concerns the gene MYC and neuroblastoma.